White Paper

Choosing The Right FSP: 4 Key Considerations To Fuel More Efficient Drug Development

Business people talking-GettyImages-1362264935

As the landscape of drug development continues to evolve, there is a shift in the trends of outsourcing models to accommodate new demands, priorities, and challenges. The strategic choice of the appropriate outsourcing model can enable developers to optimize quality, financial efficiency, operational effectiveness, and overall project success.

While the outsourcing process can vary significantly based on various factors, biotech and biopharmaceutical companies typically rely on two primary models: functional service provider (FSP) partnerships and full-service outsourcing (FSO). Some organizations also employ hybrid variations that combine elements of both models. FSO entails the outsourcing of complete clinical development services on a trial-by-trial basis, whereas FSP involves outsourcing specific functions, such as data management or monitoring, to external partners, either in part or in full.

Learn more about the benefits of using an FSP model and what four things to consider before choosing a partner.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader